Diana Naturals, Antrain, France, recently launched a new joint health formulation under the Phytonutriance® ChondrActiv™ name. ChondrActiv is a standardized, patented joint health ingredient containing a combination of collagen type 2, chondroitin sulfate and hyaluronic acid. Extracted from chicken cartilage, ChondrActiv™ has a high (55%) collagen type 2 content. It is an essential building block required to maintain the cohesion of the cartilaginous matrix (50% of the solid part of the joint cartilage is constituted by type 2 collagen fibers). The 12% chondroitin sulfate and 0.5-1.5% hyaluronic acid contribute to the permanent renewal of proteoglycans, a major biochemical component of joints.
Diana Naturals has completed a clinical trial on 37 people suffering from joint issues; results show that ChondrActiv™ decreases the consumption of non-steroidal anti-inflammatory drugs (NSAID’s) by 73% and improves mobility and quality of life. These double-blind, placebo-controlled trials were performed with a 1500 mg ChondrActiv™ daily intake against placebo for three months, with additional testing after a three month period. Additionally, ChondrActiv was the subject of an in vitro bioavailability study; results show that ChondrActiv is three times more bioavailable than native cartilage.
ChondrActiv is water dispersible and has application in tablets, capsules, powder mixes and beverages. It is also non-allergenic.
For more information:
Brian Stagg, New Business Development, North America